La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Edwards Lifesciences Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Edwards Lifesciences ha un patrimonio netto totale di $7.5B e un debito totale di $597.3M, che porta il suo rapporto debito/patrimonio netto a 8%. Le sue attività totali e le sue passività totali sono rispettivamente $10.1B e $2.6B. L'EBIT di Edwards Lifesciences è $1.9B rendendo il suo rapporto di copertura degli interessi -29.4. Ha liquidità e investimenti a breve termine pari a $2.0B.
Informazioni chiave
8.0%
Rapporto debito/patrimonio netto
US$597.30m
Debito
| Indice di copertura degli interessi | -29.4x |
| Contanti | US$1.99b |
| Patrimonio netto | US$7.50b |
| Totale passività | US$2.59b |
| Totale attività | US$10.10b |
Aggiornamenti recenti sulla salute finanziaria
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Recent updates
Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $4.5B ) di EW superano le sue passività a breve termine ( $1.2B ).
Passività a lungo termine: Le attività a breve termine di EW ( $4.5B ) superano le sue passività a lungo termine ( $1.4B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: EW ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di EW si è ridotto da 17% a 8% negli ultimi 5 anni.
Copertura del debito: Il debito di EW è ben coperto dal flusso di cassa operativo ( 145% ).
Copertura degli interessi: EW matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.